The pattern and risk factors associated with adverse drug reactions induced by Reteplase in patients with acute ST-elevation myocardial infarction: The first report from Iranian population

OBJECTIVE: Acute myocardial infarction (AMI) is one of the main leading causes of mortality and morbidity. Reteplase is a fibrin-specific thrombolytic which is used in the treatment of AMI. There is a limited number of studies reporting the postmarketing adverse drug reactions (ADRs) induced by rete...

Descripción completa

Detalles Bibliográficos
Autores principales: Aslanabadi, Naser, Safaie, Naser, Shadfar, Faezeh, Taban-Sadeghi, Mohammad Reza, Feizpour, Hossein, Mashayekhi, Simin Ozar, Hamishehkar, Hadi, Aghdam, Naser Khezerlou, Dousti, Samaneh, Namdar, Hossein, Entezari-Maleki, Taher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645133/
https://www.ncbi.nlm.nih.gov/pubmed/26645027
http://dx.doi.org/10.4103/2279-042X.167049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645133/
https://www.ncbi.nlm.nih.gov/pubmed/26645027
http://dx.doi.org/10.4103/2279-042X.167049

Ejemplares similares